MedTrace Logo

Radiochemotherapy in Elderly Patients With Oesophagus Cancer

NCT02879227 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2016-08-25

No results posted yet for this study

Summary

Phase II study of radiochemotherapy for elderly patients with oesophagus cancer.

Conditions

  • Esophagus Cancer

Interventions

DRUG

Cisplatin

Arm cisplatin : 75mg/m2, day n\*1 and day n\*22, And radiotherapy 50 Gy, 2Gy/f

DRUG

Oxaliplatin

85 mg/m2 every 2 weeks, 6 times And radiotherapy 50 Gy, 2Gy/f

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2014-12-31
Completion
2014-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02879227 on ClinicalTrials.gov